Unlock instant, AI-driven research and patent intelligence for your innovation.

Derivatives of indol-2-one for treating neurological disorders, gastrointestinal disorders and cardiovascular disorder

A Derivative, Indole Technology, Applied in 3 Fields

Inactive Publication Date: 2009-12-23
EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENY TARSASAG
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0018] However, the effects on 5-HT that have been used in therapy so far 1A Drugs for receptors come with several disadvantages and unwanted side effects
The anxiolytic effect is only achieved after the treatment lasts at least 10-14 days, which is a disadvantage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Derivatives of indol-2-one for treating neurological disorders, gastrointestinal disorders and cardiovascular disorder
  • Derivatives of indol-2-one for treating neurological disorders, gastrointestinal disorders and cardiovascular disorder
  • Derivatives of indol-2-one for treating neurological disorders, gastrointestinal disorders and cardiovascular disorder

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0096] 5-Chloro-3-ethyl-1,3-dihydro-2H-indol-2-one

[0097] 1.68 g (0.01 mole) of 5-chloro-oxindole was dissolved in 20 mL of ethanol, and 1.0 g of Raney nickel was added to the solution. The reaction mixture was reacted in an autoclave at 110° C. for 36 hours. The catalyst was then filtered off, the solvent was evaporated and the residue was recrystallized from a mixture of hexane and ethyl acetate. Yield: 0.86 g of white powder (44%).

[0098] M.p.: 121-123°C (hexane-ethyl acetate)

[0099] IR (KBr): 3156, 1701 (C=O), 782cm -1 .

[0100] 1 H-NMR (CDCl 3 ): 9.27 (br s, 1H, NH), 7.21 (1H, s, H-4), 7.19 (d, 1H, J=8.8Hz, H-6), 6.85 (d, 1H, J=8.1Hz, H-7), 3.47(t, 1H, J=5.5Hz, H-3), 2.03(m, 2H, CH 2 ), 0.92(t, 3H, J=7.0Hz, CH 3 ) ppm.

[0101] 13 C-NMR (CDCl 3 ): 180.5, 140.4, 131.2, 127.8, 127.6, 124.5, 110.7, 47.5, 23.5, 9.9ppm.

[0102] Formula C 10 h 10 Elemental analysis of ClNO (195.65):

[0103] Calculated: C 61.39, H 5.15, N 7.16, Cl 18.12%.

[0104] Found...

Embodiment 2

[0106] 5-Bromo-3-ethyl-1,3-dihydro-2H-indol-2-one

[0107] 3-Ethyloxindole (16.1 g; 0.10 mole) was dissolved in 350 mL of acetonitrile, the solution was cooled to 0° C., and N-bromosuccinimide (17.8 g; 0.10mole) in 150mL acetonitrile solution. The reaction mixture was stirred at 0°C for 1 hour and then at room temperature for 3 hours. The solution is evaporated and the white substance is isolated in crystalline form, extracted with dichloromethane and 1M NaOH solution, the organic phase is extracted again with basic water in order to remove the succinimide. The organic phase was dried over sodium sulfate, filtered and evaporated. The white material was isolated and recrystallized from a mixture of heptane and ethyl acetate. Yield: 15.24 g of white powder (63%).

[0108] M.p.: 125-127°C (heptane-ethyl acetate)

[0109] IR(KBr): 3154, 1700 (C=O), 812cm -1 .

[0110] 1 H-NMR (CDCl 3 , TMS, 400MHz): 8.90(1H, s), 7.36-7.32(2H, m), 6.81(1H, d, J=8.9Hz), 3.43(1H, t, J=5.8Hz)...

Embodiment 3

[0118] 3-(4-Chlorobutyl)-3-ethyl-1,3-hydro-2H-indol-2-one

[0119] The title compound was prepared following Procedure "A" starting from 3-ethyl-1,3-hydro-2H-indol-2-one and 1-bromo-4-chlorobutane.

[0120] M.p.: 104-105°C (hexane-ethyl acetate).

[0121] IR (KBr): 3181, 2941, 1700, 1306, 755cm -1 .

[0122] 1 H-NMR (CDCl 3 , TMS, 400MHz): 8.57 (br s, 1H, NH), 7.21 (dt, 1H, J=7.6, 1.5Hz, H-6), 7.12 (d, 1H, J=7.4Hz, H-4), 7.06(dt, 1H, J=7.5, 1.0Hz, H-5), 6.92(d, 1H, J=7.7Hz, H-7), 3.39(t, 2H, J=6.7Hz, CH 2 Cl), 1.96-1.84 (m, 2H, CH 2 ), 1.83-1.74 (m, 2H, CH 2 ), 1.74-1.60 (m, 2H, CH 2 ), 1.24-1.18(m, 1H), 1.08-1.03(m, 1H), 0.64(t, 3H, J=7.4Hz, CH 3 ) ppm.

[0123] 13 C-NMR (CDCl 3 , TMS, 101MHz): 182.4, 141.2, 132.3, 127.7, 123, 0, 122.5, 109.6, 54.1, 44.4, 36.8, 32.7, 31.0, 21.8, 8.5ppm.

[0124] Formula C 14 h 18 Elemental analysis of ClNO (251.76):

[0125] Calculated: C 66.79, H 7.21, N 5.56, Cl 14.08%.

[0126] Found values: C 66.89, H 7.16, N 5.84, Cl 14....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to novel 3,3-disubstituted indol-2-one derivatives of general formula (I). These new compounds are useful for treating or preventing disorders of the central nervous system, gastrointestinal system or cardiovascular system.

Description

technical field [0001] The present invention relates to novel 3,3-disubstituted indol-2-one derivatives, processes for their preparation, pharmaceutical compositions containing said novel indol-2-one derivatives and the use of said compounds in treating diseases . [0002] More specifically, the present invention relates to novel 3,3-disubstituted indol-2-one derivatives of general formula (I), [0003] [0004] in [0005] R 1 and R 2 independently represent hydrogen, halogen, alkyl or sulfamoyl with 1 to 7 carbon atoms; [0006] R 3 represents hydrogen or straight-chain or branched-chain alkyl having 1 to 7 carbon atoms; [0007] R 4 represents an alkyl group having 1 to 7 carbon atoms; [0008] R 5 is hydrogen, and R 6 represents phenyl optionally carrying 1 to 3 substituents selected from halogen and alkyl having 1 to 7 carbon atoms carrying 1 to 3 halogen substituents, or [0009] R 5 and R 6 together with adjacent carbon atoms of the tetrahydropyridine ri...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D401/06C07D409/06A61K31/404A61P25/00
Inventor B·沃尔克J·鲍尔科齐G·希米格T·梅泽伊R·卡皮莱尔尼德热菲I·高恰伊K·保罗吉G·吉格雷G·莱沃伊K·莫里茨C·莱韦莱基N·西拉雷G·塞纳希A·埃杰德L·G·哈尔申
Owner EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENY TARSASAG